相关实验视频
Updated: Jan 7, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.4K
[免疫疗法开始后的伪进展]
Michael Winkelmann1,2,3, Matthias Kassube1, Philipp Linden1
1Klinik und Poliklinik für Radiologie, LMU Klinikum, München, Marchioninistr. 15, 81377, München, Deutschland.
Radiologie (Heidelberg, Germany)
|December 9, 2025
概括
区分伪进步和真正的进步是很有挑战性的. 建议在怀疑伪进展的稳定患者中继续早期免疫治疗并进行成像随访.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 核医学就是核医学.
背景情况:
- 从真正的瘤进展区分伪进展是一个重要的临床和放射学挑战.
- 像CT,MRI和FDG-PET/CT这样的既定方法在确定诊断方面存在局限性.
研究的目的:
- 审查当前和新兴的方法,以区分伪进展与癌症治疗患者的真正进展.
- 突出新方法的潜力,并提供临床建议.
主要方法:
- 审查已建立的放射性成像技术,包括计算机断层扫描 (CT),磁共振成像 (MRI) 和氧糖-正子辐射断层扫描/计算机断层扫描 (FDG-PET/CT).
- 探索创新方法,如新的PET/CT标记剂,液体活检和放射学.
- 对这些技术的性能进行临床研究数据的分析.
主要成果:
- 标准的成像方法 (CT,MRI,PET/CT) 提供线索,但往往没有确定性.
- 实验室标记和放射学等新的方法显示出希望,但需要进一步的临床验证和采用.
- 目前正在进行的临床研究正在研究新的成像技术.
结论:
- 在临床稳定的患者中,在开始免疫疗法后怀疑伪进展,需要继续治疗.
- 密切的成像随访 (例如,在4-8周) 对于监测疑似伪进展的患者至关重要.
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

